Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is an American global supplier of scientific instruments, laboratory equipment, diagnostics, and biopharmaceutical services. The company operates through four primary reportable business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its comprehensive product and service lineup encompasses mass spectrometers, gene sequencing systems, clinical diagnostic tests, laboratory consumables, and contract development and manufacturing organization (CDMO) services. Principal revenue drivers consist of sales of analytical instruments and laboratory consumables, alongside long-term biopharmaceutical clinical trial and manufacturing contracts. Thermo Fisher Scientific serves broad global end markets encompassing biopharmaceutical companies, academic and research institutions, clinical diagnostic laboratories, and environmental and industrial quality control facilities. The corporation holds a leading global market position as the world's largest provider of life science tools and laboratory services by annual revenue. Headquartered in Waltham, Massachusetts, the company's common stock is publicly listed on the New York Stock Exchange under the ticker symbol TMO and is included in the S&P 500 index.
122 of the funds FundTelligence covers report a position in Thermo Fisher Scientific.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 122
Funds holding Thermo Fisher Scientific
- Swedbank Robur Healthcare — Swedbank · 5.79 % (full portfolio disclosed, October 2026)
- ODIN Global — ODIN · 5.17 % (full portfolio disclosed, September 2026)
- M&G Positive Impact — M&G Investments · 5.1 % (largest positions only, September 2026)
- Schroder ISF Hlthcr Innovt — Schroders · 4.87 % (largest positions only, September 2026)
- Handelsbanken Helse Tema — Handelsbanken · 4.43 % (full portfolio disclosed, October 2026)
- BGF World Healthscience Fund — BlackRock · 4.14 % (largest positions only, October 2026)
- Fondsforvaltning Pluss Utland Etisk — Fondsforvaltning · 4.13 % (full portfolio disclosed, October 2026)
- Fidelity Global Healthcare Fund — Fidelity · 4.1 % (largest positions only, October 2026)
Showing the 8 largest of 122 funds holding it.